Literature DB >> 24387759

Eliminating the human factor in office blood pressure measurement.

Martin G Myers1.   

Abstract

Factors related to the physician/nurse and patient and their interaction are potential sources of error in manual office blood pressure (MOBP). The use of automated sphygmomanometers to record blood pressure (BP) with the patient alone reduces measurement error and minimizes anxiety-related increases in BP, thus eliminating the "white-coat" response. Comparative studies have shown the cut-point for a normal automated office BP (AOBP), awake ambulatory BP, and home BP (<135/85 mmHg) to be similar, providing the patient does not rest for a prolonged period before the first AOBP reading, as recommended for MOBP measurement. AOBP should now replace MOBP in routine clinical practice. ©2014 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 24387759      PMCID: PMC8031951          DOI: 10.1111/jch.12252

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  30 in total

Review 1.  Reporting bias in self-measurement of blood pressure.

Authors:  M G Myers
Journal:  Blood Press Monit       Date:  2001-08       Impact factor: 1.444

2.  Evaluation of an automated sphygmomanometer for use in the office setting.

Authors:  Martin G Myers; Miguel Valdivieso
Journal:  Blood Press Monit       Date:  2012-06       Impact factor: 1.444

3.  Comparison of two automated sphygmomanometers for use in the office setting.

Authors:  Martin G Myers; Miguel Valdivieso; Alexander Kiss; Sheldon W Tobe
Journal:  Blood Press Monit       Date:  2009-02       Impact factor: 1.444

4.  Consistent relationship between automated office blood pressure recorded in different settings.

Authors:  Martin G Myers; Miguel Valdivieso; Alexander Kiss
Journal:  Blood Press Monit       Date:  2009-06       Impact factor: 1.444

Review 5.  Measurement of blood pressure in the office: recognizing the problem and proposing the solution.

Authors:  Martin G Myers; Marshall Godwin; Martin Dawes; Alexander Kiss; Sheldon W Tobe; Janusz Kaczorowski
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

6.  The effects of talking, reading, and silence on the "white coat" phenomenon in hypertensive patients.

Authors:  C Le Pailleur; G Helft; P Landais; P Montgermont; J M Feder; J P Metzger; A Vacheron
Journal:  Am J Hypertens       Date:  1998-02       Impact factor: 2.689

7.  Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies.

Authors:  Stefano Omboni; Tiziana Gazzola; Giorgia Carabelli; Gianfranco Parati
Journal:  J Hypertens       Date:  2013-03       Impact factor: 4.844

8.  The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Daniel G Hackam; Robert R Quinn; Pietro Ravani; Doreen M Rabi; Kaberi Dasgupta; Stella S Daskalopoulou; Nadia A Khan; Robert J Herman; Simon L Bacon; Lyne Cloutier; Martin Dawes; Simon W Rabkin; Richard E Gilbert; Marcel Ruzicka; Donald W McKay; Tavis S Campbell; Steven Grover; George Honos; Ernesto L Schiffrin; Peter Bolli; Thomas W Wilson; Ross D Feldman; Patrice Lindsay; Michael D Hill; Mark Gelfer; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Donna McLean; J Malcolm O Arnold; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Robert J Petrella; Alain Milot; James A Stone; Denis Drouin; Kim L Lavoie; Maxime Lamarre-Cliche; Marshall Godwin; Guy Tremblay; Pavel Hamet; George Fodor; S George Carruthers; George B Pylypchuk; Ellen Burgess; Richard Lewanczuk; George K Dresser; S Brian Penner; Robert A Hegele; Philip A McFarlane; Mukul Sharma; Debra J Reid; Sheldon W Tobe; Luc Poirier; Raj S Padwal
Journal:  Can J Cardiol       Date:  2013-03-29       Impact factor: 5.223

9.  Results of the Ontario survey on the prevalence and control of hypertension.

Authors:  Frans H H Leenen; Jean Dumais; Natalie H McInnis; Penelope Turton; Lori Stratychuk; Kathleen Nemeth; Margaret Moy Lum-Kwong; George Fodor
Journal:  CMAJ       Date:  2008-05-20       Impact factor: 8.262

10.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

View more
  13 in total

1.  William B. White Explains the Changes In the Way We Look at Blood Pressure: Which Numbers Matter Most-and Why Can They Be Deceptive?

Authors:  Jack McCain
Journal:  P T       Date:  2016-09

2.  Prevalence of pseudoresistant hypertension due to inaccurate blood pressure measurement.

Authors:  Hemal Bhatt; Mohammed Siddiqui; Eric Judd; Suzanne Oparil; David Calhoun
Journal:  J Am Soc Hypertens       Date:  2016-03-30

3.  Can auscultatory blood pressure normative values be used for evaluation of oscillometric blood pressure in children?

Authors:  Terezie Šuláková; Astrida Šuláková; Jiří Strnadel; Jan Pavlíček; Barbora Obermannová; Janusz Feber
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-11-07       Impact factor: 3.738

4.  Blood Pressure Measurement Modalities: A Primer for Busy Practitioners.

Authors:  L Allen Kindman; J Rick Turner; John Lee
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-11-12       Impact factor: 3.738

5.  Impact of Ambulatory Blood Pressure Monitoring on Reclassification of Hypertension Prevalence and Control in Older People in Spain.

Authors:  José R Banegas; Juan J de la Cruz; Auxiliadora Graciani; Esther López-García; Teresa Gijón-Conde; Luis M Ruilope; Fernando Rodriguez-Artalejo
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-16       Impact factor: 3.738

Review 6.  Contributions to Hypertension Public Policy and Clinical Practice: A Review of Recent Reports.

Authors:  Michael A Weber; Daniel T Lackland
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-08-20       Impact factor: 3.738

7.  Reply to Dr Myers' commentary on the use of automated blood pressure machines in office blood pressure measurements.

Authors:  Swapnil Hiremath; Cedric Edwards; Brendan B McCormick; Marcel Ruzicka
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-05-07       Impact factor: 3.738

8.  Comparing Automated Office Blood Pressure Readings With Other Methods of Blood Pressure Measurement for Identifying Patients With Possible Hypertension: A Systematic Review and Meta-analysis.

Authors:  Michael Roerecke; Janusz Kaczorowski; Martin G Myers
Journal:  JAMA Intern Med       Date:  2019-03-01       Impact factor: 44.409

9.  Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results.

Authors:  Robert B Hanlin; Irfan M Asif; Gregory Wozniak; Susan E Sutherland; Bijal Shah; Jianing Yang; Robert A Davis; Sean T Bryan; Michael Rakotz; Brent M Egan
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-01-05       Impact factor: 3.738

10.  Improving Hypertension Control in Primary Care With the Measure Accurately, Act Rapidly, and Partner With Patients Protocol.

Authors:  Brent M Egan; Susan E Sutherland; Michael Rakotz; Jianing Yang; R Bruce Hanlin; Robert A Davis; Gregory Wozniak
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.